News

Explore This Section

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics

Dennis Slamon UCLA Researcher

Congratulations to Dennis Slamon, M.D., Ph.D., Professor of Medicine, and Chief of the Division of Hematology/Oncology at UCLA's David Geffen School of Medicine (DGSOM) (pictured above) co-founder of TORL BioTherapeutics LLC on a successful launch!

Device developed by Dr. Abbas Ardehali could improve results for patients undergoing ECMO

Device developed by Dr. Abbas Ardehali could improve results for patients undergoing ECMO                                                      

Ardehali

                                                                                                                  Dr. Abbas Ardehali   Photo: UCLA

Opportunities for AI + Comp Med Expands with Optum Labs AI in Healthcare Hub

Opportunities for AI and Computational Medicine Expand with Launch of Optum Labs AI in Healthcare Hub

 

October 2022

UCLA Technology Development Group (TDG) and Optum Labs, the research and development arm of UnitedHealth Group, announce the launch of a research collaboration to advance artificial intelligence (AI) and machine learning (ML) in healthcare.

How the secrets of the ‘water bear’ could improve lifesaving drugs like insulin

Originally published on UCLA Newsroom https://newsroom.ucla.edu/stories/water-bear-secret-to-improving-lifesaving-medications

How the secrets of the ‘water bear’ could improve lifesaving drugs like insulin

Inspired by creatures that survive in harsh environments and aided by UCLA’s Innovation Fund, a team has invented a polymer with the potential to extend the shelf life and reach of medications